Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Two Stocks Set to Capitalize on the Surging Weight Loss Drug Trend
October 19, 2023
From TalkMarkets
Healthcare Portfolio Focus Stocks
October 16, 2023
From TalkMarkets
Psychedelic-Compound-Based Drug Stocks Continue To Fall
October 15, 2023
From TalkMarkets
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
From TalkMarkets
BIIB Stock Price Analysis: To Bet Or To Fold The Cards
October 14, 2023
Tickers
BIIB
From TalkMarkets
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
October 09, 2023
From TalkMarkets
The Canadian Cannabis Report - Monday, Oct. 9
October 09, 2023
From TalkMarkets
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
From TalkMarkets
Major Psychedelic Drug Stocks Continued To Decline This Week
October 06, 2023
From TalkMarkets
Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP!
October 06, 2023
Tickers
TNGX
From TalkMarkets
Biotech Sector: On The Verge Of Triumph Or Turmoil?
October 06, 2023
From TalkMarkets
Consolidation In Viking Therapeutics Provides An Opportunity
October 01, 2023
Tickers
VKTX
From TalkMarkets
September Summary: Largest Psychedelic Drug Stocks Dropped 14%
October 01, 2023
From TalkMarkets
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
From TalkMarkets
Some Economics Of Pharmacy Benefit Managers
September 28, 2023
From TalkMarkets
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023
From TalkMarkets
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
September 24, 2023
From TalkMarkets
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
From TalkMarkets
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
September 21, 2023
From TalkMarkets
From TalkMarkets
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
September 17, 2023
From TalkMarkets
Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy
September 16, 2023
From TalkMarkets
Healthcare Playbook Revisited - Growth Plus Value
September 13, 2023
From TalkMarkets
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
September 12, 2023
From TalkMarkets
Roivant Sciences: Is Vivek Ramaswamy’s Biotech Stock A Buy?
September 10, 2023
Tickers
ROIV
From TalkMarkets
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
September 10, 2023
From TalkMarkets
Healthcare Portfolio: A Mixed Market Looking for Value
September 05, 2023
From TalkMarkets
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.